[Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].
Lists
Only you see this
Abstract
Intracoronary administration of anisodamine is safe and could partly attenuate the no-reflow phenomenon, improve the left ventricular systolic function and synchrony and reduce the incidence of MACE in patients with no-reflow phenomenon post AMI-PCI.
BibTeX
@inproceedings{fan2007influence,
author = {Weize Fan and Xianghua Fu and Yunfa Jiang and Xinshun Gu and Weili Wu and Shiqiang Li and Jun Liu and Ling Xue and W. Yongyun and Guozhen Hao},
title = {{[Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].}},
booktitle = {PubMed},
year = {2007},
}Loading related content...